Studies with the new medium tranquilizer 4-(3-dimethylaminopropylidene)-9-10-dihydro-4H-benzo(4,5)cycloheptal(1,2-b)thiophene (IB-503) in internal medicine.
D000293:Adolescent; D000328:Adult; D000368:Aged; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D006801:Humans; D008875:Middle Aged; D011602:Psychophysiologic Disorders / Q000188:drug therapy*; D012140:Respiratory Tract Diseases / Q000188:drug therapy*; D013876:Thiophenes / Q000009:adverse effects / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use*
D013876:Thiophenes; D014149:Tranquilizing Agents
Untersuchungen mit dem neuen Medium-Tranquilizier 4-(3-Dimethylaminopropyliden)-9,10-dihydro-4H-benzo(4,5)cyclohepta(1,2-b)tiophen (IB-503) in der Inneren Medizin.